全文获取类型
收费全文 | 2732篇 |
免费 | 245篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 17篇 |
儿科学 | 40篇 |
妇产科学 | 36篇 |
基础医学 | 371篇 |
口腔科学 | 89篇 |
临床医学 | 332篇 |
内科学 | 574篇 |
皮肤病学 | 22篇 |
神经病学 | 282篇 |
特种医学 | 275篇 |
外科学 | 291篇 |
综合类 | 68篇 |
预防医学 | 236篇 |
眼科学 | 13篇 |
药学 | 150篇 |
肿瘤学 | 192篇 |
出版年
2022年 | 21篇 |
2021年 | 38篇 |
2020年 | 36篇 |
2019年 | 30篇 |
2018年 | 41篇 |
2017年 | 30篇 |
2016年 | 37篇 |
2015年 | 37篇 |
2014年 | 41篇 |
2013年 | 89篇 |
2012年 | 112篇 |
2011年 | 128篇 |
2010年 | 64篇 |
2009年 | 71篇 |
2008年 | 108篇 |
2007年 | 100篇 |
2006年 | 106篇 |
2005年 | 94篇 |
2004年 | 103篇 |
2003年 | 101篇 |
2002年 | 91篇 |
2001年 | 77篇 |
2000年 | 83篇 |
1999年 | 86篇 |
1998年 | 52篇 |
1997年 | 54篇 |
1996年 | 46篇 |
1995年 | 40篇 |
1994年 | 42篇 |
1993年 | 32篇 |
1992年 | 62篇 |
1991年 | 71篇 |
1990年 | 57篇 |
1989年 | 71篇 |
1988年 | 61篇 |
1987年 | 54篇 |
1986年 | 66篇 |
1985年 | 72篇 |
1984年 | 37篇 |
1983年 | 26篇 |
1982年 | 25篇 |
1979年 | 26篇 |
1978年 | 21篇 |
1977年 | 24篇 |
1975年 | 23篇 |
1974年 | 26篇 |
1973年 | 21篇 |
1972年 | 24篇 |
1971年 | 22篇 |
1966年 | 20篇 |
排序方式: 共有2988条查询结果,搜索用时 15 毫秒
991.
992.
993.
Christopher A.H. Hansell Samantha Love Marieke Pingen Gillian J. Wilson Megan MacLeod Gerard J. Graham 《European journal of immunology》2020,50(5):666-675
Analysis of chemokine receptor, and atypical chemokine receptor, expression is frequently hampered by the lack of availability of high-quality antibodies and the species specificity of those that are available. We have previously described methodology utilizing Alexa-Fluor-labeled chemokine ligands as versatile reagents to detect receptor expression. Previously this has been limited to hematopoietic cells and methodology for assessing expression of receptors on stromal cells has been lacking. Among chemokine receptors, the ones most frequently expressed on stromal cells belong to the atypical chemokine receptor subfamily. These receptors do not signal in the classic sense in response to ligand but scavenge their ligands and degrade them and thus sculpt in vivo chemokine gradients. Here, we demonstrate the ability to use either intratracheal or intravenous, Alexa-Fluor-labeled chemokine administration to detect stromal cell populations expressing the atypical chemokine receptor ACKR2. Using this methodology, we demonstrate, for the first time, expression of ACKR2 on blood endothelial cells. This observation sets the lung aside from other tissues in which ACKR2 is exclusively expressed on lymphatic endothelial cells and suggest unique roles for ACKR2 in the pulmonary environment. 相似文献
994.
995.
Esaú P Santos Danielle RR Cavalcante Allan UC Melo José C Pereira Margarete Z Gomes Ricardo LC Albuquerque Jr 《Head & face medicine》2011,7(1):1-6
Extracorporeal formation of mineralized bone-like tissue is still an unsolved challenge in tissue engineering. Embryonic stem cells may open up new therapeutic options for the future and should be an interesting model for the analysis of fetal organogenesis. Here we describe a technique for culturing embryonic stem cells (ESCs) in the absence of artificial scaffolds which generated mineralized miromasses. Embryonic stem cells were harvested and osteogenic differentiation was stimulated by the addition of dexamethasone, ascorbic acid, and ß-glycerolphosphate (DAG). After three days of cultivation microspheres were formed. These spherical three-dimensional cell units showed a peripheral zone consisting of densely packed cell layers surrounded by minerals that were embedded in the extracellular matrix. Alizarine red staining confirmed evidence of mineralization after 10 days of DAG stimulation in the stimulated but not in the control group. Transmission electron microscopy demonstrated scorching crystallites and collagenous fibrils as early indication of bone formation. These extracellular structures resembled hydroxyl apatite-like crystals as demonstrated by distinct diffraction patterns using electron diffraction analysis. The micromass culture technique is an appropriate model to form three-dimensional bone-like micro-units without the need for an underlying scaffold. Further studies will have to show whether the technique is applicable also to pluripotent stem cells of different origin. 相似文献
996.
997.
998.
Platelets interact with fibrin only after activation 总被引:5,自引:2,他引:5
Interactions between platelets and fibrin have been visualized by phase contrast, epifluorescence, and scanning electron microscope examination of clots formed with dansylcadaverine-labeled fibrin and gel-filtered platelets. After thrombin activation, the platelets appeared as fluorescent aggregates with bridging strands of fibrin; formaldehyde- fixed platelets were not fluorescent under the same experimental conditions. Scanning electron micrographs demonstrated that thrombin- activated cells had numerous pseudopods to which the fibrin strands adhered; fixed platelets exhibited a smooth discoid appearance and did not interact with the clot. Platelets trapped in clots formed with Batroxobin (Pentapharm) (platelets are not activated by Batroxobin as confirmed by light-scattering aggregometry measurements) remained as nonfluorescent, discoid cells, whereas platelets first activated by adenosine diphosphate formed brightly fluorescent aggregates. Light- scattering data of thrombin activation (0.2 U/mL) indicated that preincubation of platelets with 0.1 mmol/L prostaglandin E1 (PGE1) prior to addition of thrombin decreased the extent and rate of platelet shape change and resulted in 100-fold slower aggregation. Clots formed in the presence of PGE1 revealed decreased fluorescence intensity and fewer platelet-fibrin contacts. Gly-Pro-Arg-Pro, which blocks fibrinogen binding and fibrin assembly, was also effective in blocking platelet-fibrin interactions. These results indicate that platelet activation is a prerequisite for attachment of platelets to fibrin. 相似文献
999.
Love BA Collins KK Walsh EP Triedman JK 《Journal of cardiovascular electrophysiology》2001,12(1):17-25
INTRODUCTION: The electrophysiologic mechanism of intra-atrial reentrant tachycardia (IART) is generally thought to be a macroreentrant circuit revolving around a nonconductive or highly anisotropic barrier. However, the electrical and anatomic substrate that supports these circuits has been incompletely defined. Our objectives were to characterize the atria of patients with IART using electroanatomic mapping in sinus or atrially paced rhythm and to determine whether electrical barriers identified in sinus/atrially paced rhythm are associated with IART circuits. METHODS AND RESULTS: Eighteen patients with IART and a remote history of repaired or palliated congenital heart disease were studied [8 biventricular repair, 8 single ventricle palliation (7 Fontan), and 2 Mustard repair]. Thirteen patients had a right AV valve. In sinus/atrially paced rhythm, electrical evidence of a crista terminalis was identified in 11 patients, an atriotomy in 12, and > or = 1 right atrial free-wall scar in 11. In 26 IART circuits characterized, 12 used the right AV valve as a central obstacle, 6 used a right atrial free-wall scar, 3 used an atriotomy, 3 used the crista terminalis, and 2 circuits used an atrial septal scar. All central obstacles used by IART circuits were identified in sinus/atrially paced rhythm. CONCLUSION: The crista terminalis, atriotomy, and right atrial scars can be identified in patients with repaired congenital heart disease by electroanatomic mapping in sinus/atrially paced rhythm. These conduction barriers frequently function as the central obstacle for IART. Demonstration of such features may help focus investigational mapping without reliance on spontaneous initiation of the tachycardia. 相似文献
1000.
C. L. Davis A. Z. S. Rohatiner J. Lim J. S. Whelan A. M. Oza J. Amess S. Love E. Stead T. A. Lister 《British journal of haematology》1993,83(3):404-411
Summary. One hundred and sixty-two patients initially treated at St Bartholomew's Hospital between 1974 and 1988 developed recurrent acute myelogenous leukaemia (AML). In the majority, the intention was to administer intensive chemotherapy again; 22/162 were re-treated palliatively. A second complete remission (CR) was achieved in 50/126 (40%) evaluable patients. Several different regimens were employed over this time period; the treatment used was the only factor that correlated with achievement of second CR ( P =0.04). Ten of the 50 patients received myeloablative therapy with either allogeneic or autologous bone marrow transplantation in second CR. The median duration of second CR for those patients who did not proceed to intensive consolidation with bone marrow transplantation was 7 months. There was no correlation between second remission duration and age, or with the administration of either intensive or conventional consolidation therapy.
The median survival from first recurrence for all patients was 4 months, increasing to only 5 1/2 months for those re-treated with chemotherapy and to 12 months for those patients in whom a second CR was achieved, confirming the very poor prognosis of these patients. 相似文献
The median survival from first recurrence for all patients was 4 months, increasing to only 5 1/2 months for those re-treated with chemotherapy and to 12 months for those patients in whom a second CR was achieved, confirming the very poor prognosis of these patients. 相似文献